{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:03:03Z","timestamp":1762113783965,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T00:00:00Z","timestamp":1552867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00451","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T04:15:56Z","timestamp":1552882556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia"],"prefix":"10.3389","volume":"10","author":[{"given":"Xinru","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V81.5.1246.1246","article-title":"Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment","volume":"81","author":"Berchtold","year":"1993","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","article-title":"Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response","volume":"103","author":"Panitsas","year":"2004","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura","volume":"78","author":"Liu","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1182\/blood-2008-01-135335","article-title":"Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura","volume":"112","author":"Yu","year":"2008","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3324\/haematol.2009.007823","article-title":"Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura","volume":"94","author":"Zhang","year":"2009","journal-title":"Haematologica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11239-013-1036-3","article-title":"Downregulation of T-bet\/GATA-3 ratio induced by IL-11 treatment is responsible for Th1\/Th2 balance restoration in human immune thrombocytopenic purpura (ITP)","volume":"38","author":"Yao","year":"2014","journal-title":"J Thrombosis Thrombol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1365-2141.2008.07520.x","article-title":"Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura","volume":"144","author":"Shan","year":"2009","journal-title":"Br J Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08614.x","article-title":"Decreased expression of interleukin-27 in immune thrombocytopenia","volume":"153","author":"Liu","year":"2011","journal-title":"British J Haematol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bjh.13292","article-title":"Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia","volume":"169","author":"Sun","year":"2015","journal-title":"Br J Haematol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/382501b0","article-title":"Biological activity of interleukin-16","volume":"382","author":"Cruikshank","year":"1996","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1073\/pnas.94.10.5273","article-title":"Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor","volume":"94","author":"Baier","year":"1997","journal-title":"Proce Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1074\/jbc.273.2.1144","article-title":"Processing and activation of pro-interleukin-16 by caspase-3","volume":"273","author":"Zhang","year":"1998","journal-title":"J Biol Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/jcp.24441","article-title":"Regulation of cellular processes by interleukin-16 in homeostasis and cancer","volume":"229","author":"Richmond","year":"2014","journal-title":"J Cell Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1074\/jbc.M008513200","article-title":"Nuclear translocation of the N-terminal prodomain of interleukin-16","volume":"276","author":"Zhang","year":"2001","journal-title":"J Biol Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14306","DOI":"10.1021\/bi020163v","article-title":"Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization","volume":"41","author":"Wilson","year":"2002","journal-title":"Biochemistry"},{"key":"B18","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.161.6.3114","article-title":"Tissue and T cell distribution of precursor and mature IL-16","volume":"161","author":"Chupp","year":"1998","journal-title":"J Immunol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.162.3.1287","article-title":"Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent","volume":"162","author":"Wu","year":"1999","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.156.7.2566","article-title":"Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES","volume":"156","author":"Lim","year":"1996","journal-title":"J Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4049\/jimmunol.164.1.43","article-title":"Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4","volume":"164","author":"Lorentz","year":"2000","journal-title":"J Immunol J Immunol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.159.6.2904","article-title":"Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16","volume":"159","author":"Rumsaeng","year":"1997","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.4049\/jimmunol.172.12.7721","article-title":"IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis","volume":"172","author":"Elssner","year":"2004","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.4049\/jimmunol.163.6.3232","article-title":"A role for IL-16 in the cross-talk between dendritic cells and T cells","volume":"163","author":"Kaser","year":"1999","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.4049\/jimmunol.165.5.2474","article-title":"B lymphocyte-derived IL-16 attracts dendritic cells and Th cells","volume":"165","author":"Kaser","year":"2000","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/archotol.127.9.1120","article-title":"Immunohistological expression of interleukin 16 in human tonsils","volume":"127","author":"Kramer","year":"2001","journal-title":"Arch Otolaryngol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.4049\/jimmunol.138.11.3817","article-title":"Lymphokine activation of T4+ T lymphocytes and monocytes","volume":"138","author":"Cruikshank","year":"1987","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1182\/blood-2005-03-1312","article-title":"Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor","volume":"107","author":"Qi","year":"2006","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1357-2725(97)00053-8","article-title":"Interleukin-16","volume":"29","author":"Center","year":"1997","journal-title":"Int J Biochem Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2567.2000.00997.x","article-title":"Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes","volume":"100","author":"Mathy","year":"2000","journal-title":"Immunology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1742-2094-3-13","article-title":"Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions","volume":"3","author":"Skundric","year":"2006","journal-title":"J Neuroinflamm."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.2337\/db09-0131","article-title":"Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism","volume":"59","author":"Meagher","year":"2010","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1182\/blood-2013-05-502807","article-title":"Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP","volume":"122","author":"Jern\u00e5s","year":"2013","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10875-007-9111-1","article-title":"Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura","volume":"27","author":"Guo","year":"2007","journal-title":"J Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","article-title":"High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia","volume":"127","author":"Hou","year":"2016","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2011.12.012","article-title":"Methodologic issues in the measurement of interleukin-16 in clinical blood samples using immunoassays","volume":"58","author":"Goihl","year":"2012","journal-title":"Cytokine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0022-1759(97)00160-9","article-title":"A detailed protocol for the measurement of TGF-beta1 in human blood samples","volume":"209","author":"Reinhold","year":"1997","journal-title":"J Immunol Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1525-1578(10)60652-6","article-title":"A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR","volume":"3","author":"Meijerink","year":"2001","journal-title":"J Mol Diagnos."},{"key":"B41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","article-title":"The pathogenesis of immune thrombocytopaenic purpura","volume":"133","author":"Cooper","year":"2006","journal-title":"Br J Haematol."},{"key":"B42","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.157.12.5240","article-title":"IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation","volume":"157","author":"Cruikshank","year":"1996","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1067\/mai.2001.112373","article-title":"IL-16 inhibits IL-5 production by antigen-stimulated T cells in atopic subjects","volume":"107","author":"Pinsonneault","year":"2001","journal-title":"J Allergy Clinl Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.thromres.2013.10.029","article-title":"Decreased Tim-3 and its correlation with Th1 cells in patients with immune thrombocytopenia","volume":"133","author":"Shan","year":"2014","journal-title":"Thrombosis Res."},{"key":"B45","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4049\/jimmunol.157.5.1958","article-title":"CD4 ligand IL-16 inhibits the mixed lymphocyte reaction","volume":"157","author":"Theodore","year":"1996","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.4049\/jimmunol.171.10.4965","article-title":"Cutting edge: IL-16\/CD4 preferentially induces Th1 cell migration: requirement of CCR5","volume":"171","author":"Lynch","year":"2003","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12967-016-1064-9","article-title":"Pulsed high-dose dexamethasone modulates Th1-\/Th2-chemokine imbalance in immune thrombocytopenia","volume":"14","author":"Liu","year":"2016","journal-title":"J Translt Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.4049\/jimmunol.172.3.1654","article-title":"Nuclear pro-IL-16 regulation of T cell proliferation: p27(KIP1)-dependent G0\/G1 arrest mediated by inhibition of Skp2 transcription","volume":"172","author":"Center","year":"2004","journal-title":"J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"16840","DOI":"10.1074\/jbc.M115.709303","article-title":"Structure of a potential therapeutic antibody bound to interleukin-16 (IL-16): Mechanistic Insights And New Therapeutic Opportunities","volume":"291","author":"Hall","year":"2016","journal-title":"J Biol Chem."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T15:57:43Z","timestamp":1694707063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,18]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2019.00451"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00451","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2019,3,18]]},"article-number":"451"}}